Coherus Oncology, Inc.
← Back to CHRS Overview

Coherus Oncology, Inc. (CHRS)

Profitability & Net Margin History

Current Net Margin

-295.29%

Coherus Oncology, Inc. currently has a net profit margin of -295.29%.

Financial Fundamentals

CHRSQuarterly Data • 5Y View

Historical Margin Data

DateRev ($B)NI ($B)Net MarginChange (bps)
2025-12-310.01-0.04-295.29%1178
2025-09-300.01-0.04-307.07%321098
2025-06-300.010.302903.91%364834
2025-03-310.01-0.06-744.43%65080
2024-12-310.05-0.05-93.63%7844
2024-09-300.07-0.01-15.19%469
2024-06-300.06-0.01-19.88%447721
2024-03-310.000.104457.32%454435
2023-12-310.09-0.08-87.03%3387
2023-09-300.07-0.04-53.16%1985
2023-06-300.06-0.04-73.01%16046
2023-03-310.03-0.08-233.47%10367
2022-12-310.05-0.06-129.81%6095
2022-09-300.05-0.09-190.76%10738
2022-06-300.06-0.05-83.37%7646
2022-03-310.06-0.10-159.83%9751
2021-12-310.07-0.05-62.32%1562
2021-09-300.08-0.04-46.70%1258
2021-06-300.09-0.03-34.12%17417
2021-03-310.08-0.17-208.28%21708
2020-12-310.110.018.79%1581
2020-09-300.110.0324.60%1891
2020-06-300.140.0643.51%1289
2020-03-310.120.0430.62%105
2019-12-310.120.0431.67%1045
2019-09-300.110.0542.12%1387
2019-06-300.080.0228.25%8217
2019-03-310.04-0.02-53.92%
2018-12-310.00-0.06
2018-09-300.00-0.06
2018-06-300.00-0.04
2018-03-310.00-0.04
2017-12-310.00-0.05
2017-09-300.00-0.06
2017-06-300.00-0.06-3966.74%4247922
2017-03-310.00-0.07-46445.96%3745058
2016-12-310.00-0.08-8995.38%904693
2016-09-300.160.0851.55%54890
2016-06-300.01-0.07-497.35%3172
2016-03-310.01-0.07-529.07%1533
2015-12-310.01-0.05-513.74%48157
2015-09-300.01-0.07-995.31%13877
2015-06-300.01-0.06-856.54%15559
2015-03-310.01-0.04-700.95%25225
2014-12-310.01-0.03-448.70%39966
2014-09-300.02-0.01-49.04%45362
2014-06-300.00-0.02-502.66%19729
2014-03-310.00-0.03-699.94%48439
2013-12-310.00-0.01-1184.33%305934
2013-09-300.00-0.02-4243.68%252592
2013-06-300.00-0.01-1717.75%3363
2013-03-310.00-0.01-1751.38%

* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.